TransCode Therapeutics (RNAZ) Earnings Date, Estimates & Call Transcripts $13.89 +2.15 (+18.31%) Closing price 04:00 PM EasternExtended Trading$13.90 +0.01 (+0.08%) As of 05:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TransCode Therapeutics Earnings Summary TransCode Therapeutics posted Q4 2024 earnings on May 21, 2025, reporting an EPS of -$0.60, which beat the consensus estimate of -$2.00 by $1.40. With a trailing EPS of $0.00, TransCode Therapeutics' earnings are expected to grow next year, from ($4.76) to ($4.37) per share. Upcoming Earnings DateAug. 13Before Market OpensEstimatedConsensus EPS (May. 21) -$2.00 Actual EPS (May. 21) -$0.60 Beat By $1.40 Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K)RNAZ Upcoming EarningsTransCode Therapeutics' next earnings date is estimated for Wednesday, August 13, 2025, based on past reporting schedules. Powered by Get TransCode Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TransCode Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRNAZ Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. TransCode Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$56.00-$56.00-$56.00Q2 20251-$8.68-$8.68-$8.68Q3 20251-$9.24-$9.24-$9.24Q4 20251-$10.08-$10.08-$10.08 TransCode Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/13/2025(Estimated)--------5/21/2025Q4 2024-$2.00-$0.60+$1.40-$2.51$0.30M-8/14/2024Q2 2024-$535.92-$683.76 -$147.84-$0.74--5/15/2024Q1 2024-$646.80-$600.60+$46.20-$0.65--11/14/2023Q3 2023-$55,440.00-$62,092.80 -$6,652.80-$1.68--8/14/2023Q2 2023-$125,294.40-$121,598.40+$3,696.00-$3.29-- TransCode Therapeutics Earnings - Frequently Asked Questions When is TransCode Therapeutics' earnings date? TransCode Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on RNAZ's earnings history. Did TransCode Therapeutics beat their earnings estimates last quarter? In the previous quarter, TransCode Therapeutics (NASDAQ:RNAZ) reported ($0.60) earnings per share (EPS) to beat the analysts' consensus estimate of ($2.00) by $1.40. Learn more on analysts' earnings estimate vs. RNAZ's actual earnings. How much profit does TransCode Therapeutics generate each year? TransCode Therapeutics (NASDAQ:RNAZ) has a recorded net income of -$16.75 million. RNAZ has generated $0.00 earnings per share over the last four quarters. What is TransCode Therapeutics' EPS forecast for next year? TransCode Therapeutics' earnings are expected to grow from ($4.76) per share to ($4.37) per share in the next year. More Earnings Resources from MarketBeat Related Companies Clearside Biomedical Earnings Kezar Life Sciences Earnings Clene Earnings OnKure Therapeutics Earnings Rein Therapeutics Earnings FibroGen Earnings Estrella Immunopharma Earnings MIRA Pharmaceuticals Earnings Dyadic International Earnings SCYNEXIS Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Reasons Tesla's Post-Earnings Hangover Looks Like a BuyT-Mobile Earnings Show You Why This Is a Stock to HoldAmerican Airlines Earnings Miss, But Bulls Aren’t Backing OffMeta's Q2 Earnings: Key Areas Investors Must Pay Attention ToIs Former Dividend Aristocrat AT&T a Buy After Q2 Earnings?Why Freeport-McMoRan Stock May Hit a New High After Earnings BeatMicrosoft’s AI Bet Faces a Major Test This Earnings Season This page (NASDAQ:RNAZ) was last updated on 7/28/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTop 10 Green Zone Stocks to Buy NowOthers have paid $2,000 for access to stock picks like these—this weekend, you can get them free. Using a p...TradeSmith | SponsoredTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransCode Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransCode Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.